Higher incidence of new atrial fibrillation in hospitalised COVID-19 patients compared to lower respiratory tract infection, however, less patients prescribed anticoagulants at discharge
- PMID: 37775157
- PMCID: PMC10541287
- DOI: 10.7861/clinmed.2023-0188
Higher incidence of new atrial fibrillation in hospitalised COVID-19 patients compared to lower respiratory tract infection, however, less patients prescribed anticoagulants at discharge
Abstract
Infection contributes to developing cardiac arrhythmias, such as atrial fibrillation (AF), which causes over 25% of ischaemic stroke. We analysed a hospital coding database of patients hospitalised with Coronavirus 2019 (COVID-19) ± AF or a lower respiratory tract infection (LRTI) ± AF, to compare the incidence of first-diagnosed or 'new' AF (nAF) between COVID-19 and LRTI, as well as risk factors associated with developing nAF during COVID-19. In total, 2,243 patients with LRTI and 488 patients with COVID-19 were included. nAF was diagnosed in significantly more patients with COVID-19 compared with those with LRTI (7.0% vs 3.6%, p=0.003); however, significantly fewer patients with COVID-19 were discharged on anticoagulation medication (26.3% vs 56.4%, p=0.02). Patients who developed nAF during COVID-19 were older (p<0.001), had congestive cardiac failure (p=0.004), ischaemic heart disease (IHD) or peripheral vascular disease (PVD) (p<0.001) and a higher CHA2DS2-VASc score (p=0.02), compared with patients with COVID-19 patients who did not develop nAF. Older age (Odds ratio (OR) 1.03, p=0.007) and IHD/PVD (OR 2.87, p=0.01) increased the odds of developing nAF with COVID-19.
Keywords: COVID-19; anticoagulation; atrial fibrillation; ischaemic stroke; lower respiratory tract infection.
© Royal College of Physicians 2023. All rights reserved.
Conflict of interest statement
KK has received travel grants from Bayer, Boehringer Ingelheim, Daiichi-Sankyo and Pfizer. The other authors declare no conflicts of interest.
Figures
Comment in
-
COVID-19 infection as a parameter in the CHA2DS2 vascular risk assessment tool.Clin Med (Lond). 2023 Nov;23(6):646-647. doi: 10.7861/clinmed.Let.23.6.2. Clin Med (Lond). 2023. PMID: 38494331 Free PMC article. No abstract available.
References
-
- Royal College of Physicians Sentinel Stroke National Audit Programme . National clinical audit annual results portfolio April 2020–March 2021. RCP, 2022. www.strokeaudit.org/results/Clinical-audit/National-Results.aspx [Accessed 18 August 2023].
-
- Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857–67. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
